483
Gland Pharma LimitedGland Pharma Limited – FDA 483, Jul 14, 2023
Record Details
An FDA inspection of Gland Pharma Limited in Hyderabad, India, from July 3-14, 2023, revealed significant deficiencies in laboratory record-keeping. The firm failed to maintain complete data for various product tests, including injections, sub-visible particles, and sterility testing. These issues indicate a lack of adherence to established specifications and standards for laboratory controls.
View Company Profile
ID · a8b23a0b-1439-46db-b7a7-ac096d7940c7
Other documents for Gland Pharma Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.